MedTrace Logo

Occult Obscure Gastrointestinal Bleeding

NCT03464539 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2020-04-30

No results posted yet for this study

Summary

To test the activity of a polyglucosamine (PG) together with a Standard Management protocol (SM) on the occult and obscure gastrointestinal bleeding (OGIB) and the clinical symptoms in patients suffering from colonic diverticulitis (CD).

Conditions

  • Gastrointestinal Bleeding

Interventions

DIETARY_SUPPLEMENT

PG low molecular weight chitosan

The product 1000 mg of Polyglucosamine was administered three times per day before and in between main meals

Sponsors & Collaborators

  • Blymum Srl

    lead OTHER

Principal Investigators

  • Gianni Belcaro, MD · University of Chieti

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
55 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-01
Primary Completion
2017-05-15
Completion
2017-06-15

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03464539 on ClinicalTrials.gov